Bioharvest Sciences (BHST) Cash & Current Investments (2023 - 2025)
Bioharvest Sciences has reported Cash & Current Investments over the past 3 years, most recently at $23.0 million for Q4 2025.
- Quarterly results put Cash & Current Investments at $23.0 million for Q4 2025, up 863.39% from a year ago — trailing twelve months through Dec 2025 was $23.0 million (up 863.39% YoY), and the annual figure for FY2025 was $23.0 million, up 863.39%.
- Cash & Current Investments for Q4 2025 was $23.0 million at Bioharvest Sciences, up from $2.4 million in the prior quarter.
- Over the last five years, Cash & Current Investments for BHST hit a ceiling of $23.0 million in Q4 2025 and a floor of $2.4 million in Q4 2024.
- Median Cash & Current Investments over the past 3 years was $5.4 million (2023), compared with a mean of $10.3 million.
- Biggest five-year swings in Cash & Current Investments: crashed 55.37% in 2024 and later surged 863.39% in 2025.
- Bioharvest Sciences' Cash & Current Investments stood at $5.4 million in 2023, then crashed by 55.37% to $2.4 million in 2024, then surged by 863.39% to $23.0 million in 2025.
- The last three reported values for Cash & Current Investments were $23.0 million (Q4 2025), $2.4 million (Q4 2024), and $5.4 million (Q4 2023) per Business Quant data.